| Product Code: ETC7539509 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell and Gene Therapy Manufacturing Services Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell and Gene Therapy Manufacturing Services Market - Industry Life Cycle |
3.4 India Cell and Gene Therapy Manufacturing Services Market - Porter's Five Forces |
3.5 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Cell and Gene Therapy Manufacturing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in the healthcare sector in India |
4.2.2 Growing prevalence of genetic disorders and chronic diseases in the country |
4.2.3 Favorable government initiatives and policies supporting the development of cell and gene therapy manufacturing services in India |
4.3 Market Restraints |
4.3.1 High costs associated with cell and gene therapy manufacturing processes |
4.3.2 Regulatory challenges and stringent approval processes |
4.3.3 Limited awareness and acceptance of cell and gene therapies among healthcare providers and patients in India |
5 India Cell and Gene Therapy Manufacturing Services Market Trends |
6 India Cell and Gene Therapy Manufacturing Services Market, By Types |
6.1 India Cell and Gene Therapy Manufacturing Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 India Cell and Gene Therapy Manufacturing Services Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Oncology Diseases, 2021- 2031F |
6.2.3 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Orthopedic Diseases, 2021- 2031F |
6.2.5 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Ophthalmology Diseases, 2021- 2031F |
6.2.6 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Central Nervous System Disorder, 2021- 2031F |
6.2.7 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 India Cell and Gene Therapy Manufacturing Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Clinical Manufacturing, 2021- 2031F |
6.3.3 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Commercial Manufacturing, 2021- 2031F |
6.4 India Cell and Gene Therapy Manufacturing Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.4 India Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 India Cell and Gene Therapy Manufacturing Services Market Import-Export Trade Statistics |
7.1 India Cell and Gene Therapy Manufacturing Services Market Export to Major Countries |
7.2 India Cell and Gene Therapy Manufacturing Services Market Imports from Major Countries |
8 India Cell and Gene Therapy Manufacturing Services Market Key Performance Indicators |
8.1 Number of research collaborations and partnerships in the cell and gene therapy manufacturing sector in India |
8.2 Growth in the number of clinical trials for cell and gene therapies conducted in India |
8.3 Increase in the number of skilled professionals and specialized facilities for cell and gene therapy manufacturing in the country |
9 India Cell and Gene Therapy Manufacturing Services Market - Opportunity Assessment |
9.1 India Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Cell and Gene Therapy Manufacturing Services Market - Competitive Landscape |
10.1 India Cell and Gene Therapy Manufacturing Services Market Revenue Share, By Companies, 2024 |
10.2 India Cell and Gene Therapy Manufacturing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here